<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pulmo</journal-id><journal-title-group><journal-title xml:lang="ru">Пульмонология</journal-title><trans-title-group xml:lang="en"><trans-title>PULMONOLOGIYA</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0869-0189</issn><issn pub-type="epub">2541-9617</issn><publisher><publisher-name>Scientific and Practical Journal “PULMONOLOGIYA” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18093/0869-0189-2017-27-3-311-319</article-id><article-id custom-type="elpub" pub-id-type="custom">pulmo-874</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПЕРЕДОВАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EDITORIAL</subject></subj-group></article-categories><title-group><article-title>Болезни, ассоциированные с иммуноглобулином G</article-title><trans-title-group xml:lang="en"><trans-title>IgG-related diseases</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чучалин</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Chuchalin</surname><given-names>Aleksandr G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м. н., профессор, академик Российской академии наук, заведующий кафедрой госпитальной терапии педиатрического факультета Федерального государственного бюджетного образовательного учреждения высшего образования «Российский национальный исследовательский медицинский университет имени Н.И.Пирогова» Министерства здравоохранения Российской Федерации, 117997, Москва, ул. Островитянова, 1; председатель правления Российского респираторного общества; тел.: (499) 780-08-50</p></bio><bio xml:lang="en"><p>Doctor of Medicine, Professor, Academician of Russian Science Academy, Head of Department of Hospital Internal Medicine. Pediatric Faculty, N.I.Pirogov Russian State National Research Medical University;ul. Ostrovityanova 1, Moscow, 117997, Russ; Healthcare Ministry of Russia; President of Russian Respiratory Society; tel.: (499) 780-08-50;</p></bio><email xlink:type="simple">pulmomoskva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Российский национальный исследовательский медицинский университет имени Н.И.Пирогова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I.Pirogov Russian State National Research Medical University, Healthcare Ministry of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>28</day><month>08</month><year>2017</year></pub-date><volume>27</volume><issue>3</issue><fpage>311</fpage><lpage>319</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чучалин А.Г., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Чучалин А.Г.</copyright-holder><copyright-holder xml:lang="en">Chuchalin A.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.pulmonology.ru/pulm/article/view/874">https://journal.pulmonology.ru/pulm/article/view/874</self-uri><abstract><p>По результатам исследований последних лет в области иммунного статуса человека выделена группа болезней, ассоциированных с нарушенным синтезом иммуноглобулина (Ig) G. Ig играет ключевую роль в формировании защиты организма человека от инвазии патогенных микроорганизмов и инородных частиц; его биологическая функция состоит в инициации процесса опсонизации патогенов, внедрившихся в организм человека. Другой важной биологической ролью IgG является активация системы комплемента. Как биологический маркер Ig может быть применен в диагностическом процессе при рецидивирующих инфекционных заболеваниях верхнего и нижнего отделов дыхательных путей, бронхиальной астме, бронхоэктазии, васкулитах, миеломной болезни и многих других заболеваниях. Целью данного обзора явился анализ роли не только дефицита синтеза IgG, но и его повышенной продукции в диагностике и лечении ряда заболеваний. По результатам эпидемиологических исследований по выявлению распространенности иммунодефицита IgG (как на популяционном уровне, так и в целевых группах больных с частыми эпизодами респираторной инфекции) при дефиците IgG2 отмечена предрасположенность к инфекции, вызванной Streptococcus pneumoniae, Haemophilus influenzae-b, Neisseria meningitidis. Доминируют такие заболевания, как отит среднего уха, синусит, рецидивы бронхита. В более тяжелых случаях развивается пневмония, менингококцемия. При частых обострениях легочных инфекционных заболеваний развиваются бронхоэктазы. Особое место занимает селективное повышение концентрации IgG4, ассоциируемое с формированием идиопатических фиброзов. Так, в клинической практике описаны ретроперитонеальный фиброз, аутоиммунный панкреатит, склерозирующий холангит, гипертрофия слюнных желез, сиаладенит, интерстициальная пневмония и т. п. Данной статьей открывается цикл публикаций на тему заболеваний, ассоциированных с нарушением синтеза IgG. Подробно рассматриваются патогенез, клиническая картина и терапия фиброзов, обусловленных повышенной продукцией IgG4. В дальнейшем будут рассмотрены другие заболевания.</p></abstract><trans-abstract xml:lang="en"><p>Recent investigations in immunology resulted in recognition of diseases related to abnormal synthesis of immunoglobulin G (IgG). IgG plays the key role for human defense from pathogens and foreign particles. The biological function of IgG is to initiate opsonisation of pathogens. Another important function of IgG is activation of the complement. As a biological marker, IgG could be used for diagnosis of recurrent infections of lower and upper airways, asthma, bronchiectasis, vasculitis, multiple myeloma, etc. This review is aimed at a role of both IgG deficiency and hyperproduction for diagnosis and treatment of various diseases. Prevalence of IgG deficiency was investigated in epidemiological studies, both in population level and in selected groups of patients with recurrent respiratory infections. The results showed susceptibility to Streptococcus pneumoniae, Haemophilus influenzae-b, and Neisseria meningitidis, infections in patients with IgG2 deficiency. The most common diseases were of it media, sinusitis, and recurrent bronchitis. Pneumonia and meningococcemia occurred in severe cases. Bronchiectasis occurred in patients with frequent episodes of respiratory infection. A selective increase in IgG4 level is particularly important as it is associated with development of idiopathic fibrosis. Retroperitoneal fibrosis, autoimmune pancreatitis, sclerosing cholangitis, salivary gland hypertrophy, sialadenitis, interstitial pneumonias, etc., were reported. This is the first article in a series of publications about IgG-related diseases. Pathogenesis, clinical symptoms and therapy of fibrosis associated with IgG4 hyperproduction have been described in the review. Further publications will discuss other IgG-related diseases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>иммуноглобулин G</kwd><kwd>опсонизация патогенов</kwd><kwd>дефицит синтеза иммуноглобулина G</kwd><kwd>повышенная продукция иммуноглобулина G</kwd><kwd>инфекция</kwd><kwd>идиопатический фиброз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>immunoglobulin G</kwd><kwd>opsonisation of pathogens</kwd><kwd>IgG deficiency</kwd><kwd>IgG hyperproduction</kwd><kwd>infection</kwd><kwd>idiopathic fibrosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">​Pan Q., Hammarström L. Molecular basis of IgG subclass deficiency. J. Immunol. Rev. 2000; 178: 99–110.</mixed-citation><mixed-citation xml:lang="en">​Pan Q., Hammarström L. Molecular basis of IgG subclass deficiency. J. Immunol. Rev. 2000; 178: 99–110.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">​Burton D.R., Gregory L., Jefferis R. Aspects of the molecular structure of IgG subclasses. Monogr. Allergy. 1986; 19: 7–35.</mixed-citation><mixed-citation xml:lang="en">​Burton D.R., Gregory L., Jefferis R. Aspects of the molecular structure of IgG subclasses. Monogr. Allergy. 1986; 19: 7–35.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">​van der Berg M., Weemaes C.M.R., Cunningham-Rundles C. Isotype defects. In: Sullivan K.E., Stiehm E.R., eds. Immune Deficiencies. Amsterdam: Academic Press Elsevier; 2014.</mixed-citation><mixed-citation xml:lang="en">​van der Berg M., Weemaes C.M.R., Cunningham-Rundles C. Isotype defects. In: Sullivan K.E., Stiehm E.R., eds. Immune Deficiencies. Amsterdam: Academic Press Elsevier; 2014.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">​Jefferis R., Pound J., Lund J., Goodall M. Effector mechanisms activated by human IgG subclass antibodies: clinical and molecular aspects. Ann. Biol. Clin. (Paris). 1994; 52 (1): 57–65.</mixed-citation><mixed-citation xml:lang="en">​Jefferis R., Pound J., Lund J., Goodall M. Effector mechanisms activated by human IgG subclass antibodies: clinical and molecular aspects. Ann. Biol. Clin. (Paris). 1994; 52 (1): 57–65.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">​Pumphrey R.S. Computer models of the human immunoglobulins shape and segmental flexibility. Immunol. Today. 1986; 7 (6): 17457.</mixed-citation><mixed-citation xml:lang="en">​Pumphrey R.S. Computer models of the human immunoglobulins shape and segmental flexibility. Immunol. Today. 1986; 7 (6): 17457.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">​Lee S.I., Heiner D.C., Wara D. Development of serum IgG subclass levels in children. Monogr. Allergy. 1986; 19: 108–121.</mixed-citation><mixed-citation xml:lang="en">​Lee S.I., Heiner D.C., Wara D. Development of serum IgG subclass levels in children. Monogr. Allergy. 1986; 19: 108–121.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">​Morell A., Terry W.D., Waldmann T.A. Metabolic properties of IgG subclasses in man. J. Clin. Invest. 1970; 49 (4): 673–680.</mixed-citation><mixed-citation xml:lang="en">​Morell A., Terry W.D., Waldmann T.A. Metabolic properties of IgG subclasses in man. J. Clin. Invest. 1970; 49 (4): 673–680.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">​Jefferis R., Reimer C.B., Skvaril F. et al. Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol. Lett. 1985; 10 (3–4): 223–252.</mixed-citation><mixed-citation xml:lang="en">​Jefferis R., Reimer C.B., Skvaril F. et al. Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol. Lett. 1985; 10 (3–4): 223–252.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">​Braconier J.H., Nilsson B., Oxelius V.A., Karup-Pedersen F. Recurrent pneumococcal infections in a patient with lack of specific IgG and IgM pneumococcal antibodies and deficiency of serum IgA, IgG2 and IgG4. Scand. J. Infect. Dis. 1984; 16 (4): 407.</mixed-citation><mixed-citation xml:lang="en">​Braconier J.H., Nilsson B., Oxelius V.A., Karup-Pedersen F. Recurrent pneumococcal infections in a patient with lack of specific IgG and IgM pneumococcal antibodies and deficiency of serum IgA, IgG2 and IgG4. Scand. J. Infect. Dis. 1984; 16 (4): 407.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">​Hammarström L., Smith C.I. IgG subclasses in bacterial infections. Monogr. Allergy. 1986; 19: 122.</mixed-citation><mixed-citation xml:lang="en">​Hammarström L., Smith C.I. IgG subclasses in bacterial infections. Monogr. Allergy. 1986; 19: 122.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">​Briere E.C., Rubin L., Moro P.L. et al. Prevention and control of Haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep. 2014; 63 (RR-01): 1–14.</mixed-citation><mixed-citation xml:lang="en">​Briere E.C., Rubin L., Moro P.L. et al. Prevention and control of Haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep. 2014; 63 (RR-01): 1–14.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">​Stone J.H., Zen Y., Deshpande V. IgG4-related disease. N. Engl. J. Med. 2012; 366 (6): 539–51. DOI: 10.1056/NEJMra1104650.</mixed-citation><mixed-citation xml:lang="en">​Stone J.H., Zen Y., Deshpande V. IgG4-related disease. N. Engl. J. Med. 2012; 366 (6): 539–51. DOI: 10.1056/NEJMra1104650.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">​Kamisawa T., Zen Y., Pillai S., Stone J H. IgG4-related disease. Lancet. 2015; 385 (9976): 1460–1471. DOI: 10.1016/S0140-6736(14)60720-0.</mixed-citation><mixed-citation xml:lang="en">​Kamisawa T., Zen Y., Pillai S., Stone J H. IgG4-related disease. Lancet. 2015; 385 (9976): 1460–1471. DOI: 10.1016/S0140-6736(14)60720-0.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">​Khosroshahi A., Stone J.H. A clinical overview of IgG4-related systemic disease. Curr. Opin. Rheumatol. 2011; 23 (1): 57–66. DOI: 10.1097/BOR.0b013e3283418057.</mixed-citation><mixed-citation xml:lang="en">​Khosroshahi A., Stone J.H. A clinical overview of IgG4-related systemic disease. Curr. Opin. Rheumatol. 2011; 23 (1): 57–66. DOI: 10.1097/BOR.0b013e3283418057.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">​Okazaki K., Uchida K., Koyabu M. et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J. Gastroenterol. 2011; 46 (3): 277–288. DOI: 10.1007/s00535-011-0386-x.</mixed-citation><mixed-citation xml:lang="en">​Okazaki K., Uchida K., Koyabu M. et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J. Gastroenterol. 2011; 46 (3): 277–288. DOI: 10.1007/s00535-011-0386-x.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">​Umehara H., Okazaki K., Masaki Y. et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod. Rheumatol. 2012; 22 (1): 1–14. DOI: 10.1007/s10165-011-0508-6.</mixed-citation><mixed-citation xml:lang="en">​Umehara H., Okazaki K., Masaki Y. et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod. Rheumatol. 2012; 22 (1): 1–14. DOI: 10.1007/s10165-011-0508-6.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">​Aalberse R.C., Stapel S.O., Schuurman J., Rispens T. Immunoglobulin IG4: an odd antibody. Clin. Exp. Allergy. 2009; 39 (4): 469–477. DOI: 10.1111/j.1365-2222.2009.03207.x.</mixed-citation><mixed-citation xml:lang="en">​Aalberse R.C., Stapel S.O., Schuurman J., Rispens T. Immunoglobulin IG4: an odd antibody. Clin. Exp. Allergy. 2009; 39 (4): 469–477. DOI: 10.1111/j.1365-2222.2009.03207.x.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">​Zen Y., Nakanuma Y. Pathogenesis of IgG4-related disease. Curr. Opin. Rheumatol. 2011; 23 (1): 114–118. DOI: 10.1097/BOR.0b013e3283412f4a.</mixed-citation><mixed-citation xml:lang="en">​Zen Y., Nakanuma Y. Pathogenesis of IgG4-related disease. Curr. Opin. Rheumatol. 2011; 23 (1): 114–118. DOI: 10.1097/BOR.0b013e3283412f4a.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">​Sah R.P., Chari S.T., Pannala R. et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010; 139 (1): 140–148. DOI: 10.1053/j.gastro.2010.03.054.</mixed-citation><mixed-citation xml:lang="en">​Sah R.P., Chari S.T., Pannala R. et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010; 139 (1): 140–148. DOI: 10.1053/j.gastro.2010.03.054.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">​Matsui S., Yamamoto H., Minamoto S. et al. Proposed diagnostic criteria for IgG4-related respiratory disease. Respir. Invest. 2016; 54 (2): 130–132. DOI: 10.1016/j.resinv.2015.09.002.</mixed-citation><mixed-citation xml:lang="en">​Matsui S., Yamamoto H., Minamoto S. et al. Proposed diagnostic criteria for IgG4-related respiratory disease. Respir. Invest. 2016; 54 (2): 130–132. DOI: 10.1016/j.resinv.2015.09.002.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">​Saeki T., Nishi S., Imai N. et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010; 78 (10): 1016–1023. DOI: 10.1038/ki.2010.271.</mixed-citation><mixed-citation xml:lang="en">​Saeki T., Nishi S., Imai N. et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010; 78 (10): 1016–1023. DOI: 10.1038/ki.2010.271.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">​Hao M., Liu M., Fan G. et al. Diagnostic value of serum IgG4 for IgG4-related disease: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016; 95 (21): e3785. DOI: 10.1097/MD.0000000000003785.</mixed-citation><mixed-citation xml:lang="en">​Hao M., Liu M., Fan G. et al. Diagnostic value of serum IgG4 for IgG4-related disease: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016; 95 (21): e3785. DOI: 10.1097/MD.0000000000003785.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">​Khosroshahi A., Wallace Z.S., Crowe J.L. et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthrit. Rheumatol. 2015; 67 (7): 1688–1699. DOI: 10.1002/art.39132.</mixed-citation><mixed-citation xml:lang="en">​Khosroshahi A., Wallace Z.S., Crowe J.L. et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthrit. Rheumatol. 2015; 67 (7): 1688–1699. DOI: 10.1002/art.39132.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
